Abstract
Tumour staging in cancer patients generally entails a multimodality imaging approach. Whole-body (WB) imaging techniques may, however, be more time- and cost-effective than a multimodality approach. 2-Fluorine-18-fluoro-2-deoxy-d-glucose positron emission tomography ((18)FDG-PET), computed tomography (CT) and hybrid positron emission tomography and computed tomography (PET/CT) are the most established WB modalities, although new techniques, amongst which diffusion-weighted magnetic resonance imaging (DWI), are emerging. This review aims to evaluate the current evidence for WB-DWI in oncology, to discuss its potential for the WB staging of (colo)rectal cancer and to relate it to the established WB techniques.
Original language | English |
---|---|
Pages (from-to) | 2107-2116 |
Number of pages | 10 |
Journal | European Journal of Cancer |
Volume | 47 |
Issue number | 14 |
DOIs | |
Publication status | Published - Sept 2011 |
Keywords
- Diffusion magnetic resonance imaging
- Whole body imaging
- Neoplasm staging
- Colorectal neoplasms
- POSITRON-EMISSION-TOMOGRAPHY
- PRIMARY RECTAL-CARCINOMA
- FOCAL LIVER-LESIONS
- CELL LUNG-CANCER
- HIGH-B-VALUE
- HEPATIC METASTASES
- PET-CT
- MALIGNANT-LYMPHOMA
- RADIATION-THERAPY
- ADC MEASUREMENTS